ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 117 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $24,000 | +4.3% | 13,439 | -2.1% | 0.00% | – |
| Q2 2016 | $23,000 | 0.0% | 13,733 | +16.9% | 0.00% | – |
| Q1 2016 | $23,000 | -73.6% | 11,748 | -37.4% | 0.00% | – |
| Q2 2015 | $87,000 | -11.2% | 18,759 | -16.6% | 0.00% | – |
| Q1 2015 | $98,000 | +18.1% | 22,494 | -5.5% | 0.00% | – |
| Q4 2014 | $83,000 | -23.1% | 23,815 | -7.5% | 0.00% | – |
| Q3 2014 | $108,000 | -29.9% | 25,740 | +5.2% | 0.00% | – |
| Q1 2014 | $154,000 | +10.8% | 24,474 | +2.9% | 0.00% | – |
| Q4 2013 | $139,000 | +14.9% | 23,790 | +3.7% | 0.00% | – |
| Q3 2013 | $121,000 | -56.0% | 22,934 | -35.8% | 0.00% | -100.0% |
| Q2 2013 | $275,000 | – | 35,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |